Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2020
Historique:
received: 03 02 2020
accepted: 02 04 2020
entrez: 12 5 2020
pubmed: 12 5 2020
medline: 27 5 2021
Statut: epublish

Résumé

The methylation levels of

Identifiants

pubmed: 32390948
doi: 10.3389/fendo.2020.00245
pmc: PMC7191069
doi:

Substances chimiques

Biomarkers, Tumor 0
DNA-Binding Proteins 0
Transcription Factors 0
zinc finger protein 577, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

245

Informations de copyright

Copyright © 2020 Lorenzo, Izquierdo, Diaz-Lagares, Carreira, Macias-Gonzalez, Sandoval, Cueva, Lopez-Lopez, Casanueva and Crujeiras.

Références

Int J Cancer. 2018 Jan 15;142(2):230-237
pubmed: 28913916
PLoS Biol. 2012;10(11):e1001433
pubmed: 23209378
Biochim Biophys Acta Gene Regul Mech. 2019 Jun;1862(6):643-656
pubmed: 30959128
Nutrients. 2019 Sep 09;11(9):
pubmed: 31505794
Epigenetics. 2011 May;6(5):623-9
pubmed: 21739720
Breast Cancer Res Treat. 2015 Jul;152(1):155-162
pubmed: 26044369
Nat Commun. 2017 Mar 22;8:14824
pubmed: 28327662
Nat Rev Endocrinol. 2019 May;15(5):288-298
pubmed: 30814686
Sci Rep. 2017 Feb 17;7:41903
pubmed: 28211912
Epigenetics. 2019 Oct;14(10):977-988
pubmed: 31179817
Mamm Genome. 2019 Aug;30(7-8):226-236
pubmed: 31321500
Anticancer Agents Med Chem. 2019;19(3):330-336
pubmed: 30338745
Endocr Relat Cancer. 2017 Jul;24(7):351-363
pubmed: 28442560
Clin Nutr. 2017 Feb;36(1):65-78
pubmed: 26833289
J Physiol Biochem. 2016 Aug;73(3):445-455
pubmed: 28181167
Cell Rep. 2018 Jan 9;22(2):523-534
pubmed: 29320745
Breast Cancer Res. 2019 Mar 1;21(1):35
pubmed: 30823902
Nihon Eiseigaku Zasshi. 2016;71(3):200-207
pubmed: 27725423
Regul Pept. 2013 Sep 10;186:1-6
pubmed: 23831408
Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):E7535-E7544
pubmed: 27821766
Nutrition. 2020 Feb;70:110499
pubmed: 31655468
Clin Epigenetics. 2017 Oct 13;9:110
pubmed: 29046732
Int J Mol Sci. 2017 Jun 27;18(7):
pubmed: 28653987
Nutrients. 2018 Mar 08;10(3):
pubmed: 29518016
Epigenetics. 2011 Mar;6(3):293-9
pubmed: 21178401
Nutrients. 2017 Feb 08;9(2):
pubmed: 28208713
Int J Obes (Lond). 2019 Jan;43(1):176-188
pubmed: 29717273
Clin Epigenetics. 2017 Apr 26;9:43
pubmed: 28450971
J Nutr. 2011 Jun;141(6):1165-71
pubmed: 21525250
J Nutr. 2011 Jun;141(6):1140-5
pubmed: 21508208
Int J Mol Sci. 2019 Sep 23;20(19):
pubmed: 31547615
Curr Opin Clin Nutr Metab Care. 2018 Jul;21(4):252-259
pubmed: 29847446
Br J Pharmacol. 2020 Mar;177(6):1331-1350
pubmed: 31691272
Front Genet. 2018 Oct 30;9:514
pubmed: 30425730
Int J Biol Sci. 2017 Nov 1;13(11):1387-1397
pubmed: 29209143
Nature. 2010 Mar 25;464(7288):619-23
pubmed: 20200519
Clin Epigenetics. 2015 Jun 10;7:60
pubmed: 26110043
FASEB J. 2011 Apr;25(4):1378-89
pubmed: 21209057
Results Probl Cell Differ. 2010;52:57-68
pubmed: 20865372
Transl Res. 2016 Dec;178:13-24.e5
pubmed: 27477082
Nutrients. 2017 Sep 26;9(10):
pubmed: 28954418
J Intern Med. 2014 May;275(5):522-33
pubmed: 24283382
FASEB J. 2018 Sep;32(9):5012-5025
pubmed: 29913553
J Endocrinol Invest. 2012 Jul;35(7):681-5
pubmed: 22522745
Bioessays. 2014 May;36(5):526-37
pubmed: 24706458
Int J Cancer. 2018 Dec 1;143(11):2787-2799
pubmed: 30183083
Mol Nutr Food Res. 2017 Jan;61(1):
pubmed: 27138454
Am J Clin Nutr. 2017 Oct;106(4):1157-1165
pubmed: 28855224
Lancet. 2014 Jun 7;383(9933):1990-8
pubmed: 24630777
Endocr Relat Cancer. 2006 Jun;13(2):279-92
pubmed: 16728564
Cell Biosci. 2014 Aug 19;4:45
pubmed: 25949794
Lancet Oncol. 2015 Dec;16(16):1599-600
pubmed: 26514947
Epigenetics. 2011 Jun;6(6):692-702
pubmed: 21593595
Lancet Diabetes Endocrinol. 2015 Jul;3(7):526-534
pubmed: 26095709
Epigenetics. 2013 Oct;8(10):1080-8
pubmed: 23974009
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459
Endocr Rev. 2018 Apr 1;39(2):79-132
pubmed: 29518206
Am J Physiol Endocrinol Metab. 2018 Oct 1;315(4):E676-E693
pubmed: 29509432
Clin Epigenetics. 2015 Apr 02;7:39
pubmed: 25866590
Prog Mol Biol Transl Sci. 2010;94:291-347
pubmed: 21036330

Auteurs

Paula M Lorenzo (PM)

Laboratory of Epigenomics in Endocrinology and Nutrition (EpiEndoNut), Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago de Compostela (CHUS/SERGAS), Santiago de Compostela, Spain.

Andrea G Izquierdo (AG)

Laboratory of Epigenomics in Endocrinology and Nutrition (EpiEndoNut), Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago de Compostela (CHUS/SERGAS), Santiago de Compostela, Spain.
CIBER de Fisiopatologia de la Obesidad y Nutricion (CIBEOBN), Instituto de Salud Carlos III, Madrid, Spain.

Angel Diaz-Lagares (A)

Cancer Epigenetics, Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain.
CIBER de Oncologia (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.

Marcos C Carreira (MC)

CIBER de Fisiopatologia de la Obesidad y Nutricion (CIBEOBN), Instituto de Salud Carlos III, Madrid, Spain.
Laboratory of Molecular and Cellular Endocrinology, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago de Compostela (CHUS/SERGAS) and Santiago de Compostela University (USC), Santiago de Compostela, Spain.

Manuel Macias-Gonzalez (M)

CIBER de Fisiopatologia de la Obesidad y Nutricion (CIBEOBN), Instituto de Salud Carlos III, Madrid, Spain.
Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, University of Malaga (IBIMA) and CIBEROBN, Málaga, Spain.

Juan Sandoval (J)

Biomarkers and Precision Medicine Unit and Epigenomics Core Facility, Health Research Institute La Fe, Valencia, Spain.

Juan Cueva (J)

Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain.

Rafael Lopez-Lopez (R)

CIBER de Oncologia (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
Translational Medical Oncology (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain.

Felipe F Casanueva (FF)

CIBER de Fisiopatologia de la Obesidad y Nutricion (CIBEOBN), Instituto de Salud Carlos III, Madrid, Spain.
Laboratory of Molecular and Cellular Endocrinology, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago de Compostela (CHUS/SERGAS) and Santiago de Compostela University (USC), Santiago de Compostela, Spain.

Ana B Crujeiras (AB)

Laboratory of Epigenomics in Endocrinology and Nutrition (EpiEndoNut), Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago de Compostela (CHUS/SERGAS), Santiago de Compostela, Spain.
CIBER de Fisiopatologia de la Obesidad y Nutricion (CIBEOBN), Instituto de Salud Carlos III, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH